Rockwell Medical Inc.

RMTI | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.69

-$0.01 (-0.11%)

Sep 22, 2026, 2:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.11%

(1D)

Rating

Updated: Aug 13, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $34.3M

1D Range

8.46 8.84

52W Range

4.89 13.30

Valuation (TTM)

PE -6.40

PB 1.00

EV/EBITDA -10.37

Valuation (NTM)

Forward PE N/A

Forward PEG 0.08

Price Target $20

Cash Flow

FCF Yield 4.4%

SBC Adj. FCF Yield -0.9%

SBC Impact -121.5%

Margins

Gross Margin 17.7%

Operating Margin -6.5%

FCF Margin 2.2%

Growth (CAGR)

Revenue 3Y | 5Y -2.9% | 2.6%

Dil EPS 3Y | 5Y 13.0% | 78.6%

FCF 3Y | 5Y 1019.8% | 95.2%

Returns

ROA -9.0%

ROE -14.0%

ROIC -9.2%

Financial Health

Net Cash

$15.79M

Current Ratio 3.25

Interest Coverage -3.99

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range o...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 157

IPO Date Jan 26, 1998

Website www.rockwellmed.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20

Upside

+130.15%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞